LOC147646: A Potential Drug Target and Biomarker for Cancer (G147646)

Target Name: C19orf84

NCBI ID: G147646

C19orf84

LOC147646: A Potential Drug Target and Biomarker for Cancer

Introduction

LOC147646 is a gene located on chromosome 19q36.2, which encodes a protein known as B-cell lymphoid receptor (BCR) alpha chain. BCR is a transmembrane protein that plays a crucial role in the development and activation of B cells, which are responsible for producing antibodies to fight off infections and diseases. Mutations in the LOC147646 gene have been linked to various human diseases, including cancer. Therefore, identifying potential drug targets and biomarkers for LOC147646 could have a significant impact on cancer research and treatment.

Potential Drug Targets

LOC147646 has been associated with the BCR signaling pathway, which is a critical pathway involved in cell growth, differentiation, and survival. Many studies have identified potential drug targets in the BCR signaling pathway based on the presence of gene alterations, including mutations, gene fusions , and gene deletions. Some of these potential drug targets include:

1. BCR signaling pathway: BCR signaling is a complex process that involves various proteins, including tyrosine kinases, phosphateases, and scaffolds. Therefore, targeting the BCR signaling pathway could be an effective way to inhibit the activity of cancer cells.
2. DNA damage response: The DNA damage response is a critical signaling pathway that involves various proteins, including DNA-binding proteins, DNA polymerases, and DNA repair proteins. Alterations in the DNA damage response have been linked to cancer development. Therefore, targeting this pathway could be an effective way to inhibit the activity of cancer cells.
3. Cell cycle: The cell cycle is the process by which cells grow, divide, and replicate their genetic material. Disruptions in the cell cycle have been linked to various diseases, including cancer. Therefore, targeting the cell cycle could be an effective way to inhibit the activity of cancer cells.

Potential Biomarkers

LOC147646 has also been associated with the development and progression of cancer. Therefore, identifying potential biomarkers for LOC147646 could have a significant impact on cancer diagnosis and treatment. Some of the potential biomarkers for LOC147646 include:

1. BCR伪 expression: BCR伪 is a protein that is encoded by the LOC147646 gene. Therefore, measuring BCR伪 expression levels could be an effective way to identify potential biomarkers for LOC147646.
2. BCR signaling pathway activity: As mentioned earlier, the BCR signaling pathway is involved in cell growth, differentiation, and survival. Therefore, measuring the activity of the BCR signaling pathway could be an effective way to identify potential biomarkers for LOC147646.
3. DNA damage response: The DNA damage response is a critical signaling pathway that involves various proteins, including DNA-binding proteins, DNA polymerases, and DNA repair proteins. Therefore, measuring the DNA damage response could be an effective way to identify potential biomarkers for LOC147646.
4. Cell cycle: The cell cycle is the process by which cells grow, divide, and replicate their genetic material. Therefore, measuring the cell cycle could be an effective way to identify potential biomarkers for LOC147646.

Conclusion

LOC147646 is a gene located on chromosome 19q36.2 that encodes a protein known as B-cell lymphoid receptor (BCR) alpha chain. The BCR signaling pathway is a critical pathway involved in cell growth, differentiation, and survival, and has been associated with the development and progression of cancer. Therefore, targeting the BCR signaling pathway and identifying potential drug targets and biomarkers for LOC147646 could have a significant impact on cancer research and treatment. Further studies are needed to

Protein Name: Chromosome 19 Open Reading Frame 84

The "C19orf84 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about C19orf84 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets